Cargando…
Biologics in steroid resistant nephrotic syndrome in childhood: review and new hypothesis-driven treatment
Nephrotic syndrome affects about 2–7 per 100,000 children yearly and accounts for less than 15% of end stage kidney disease. Steroids still represent the cornerstone of therapy achieving remission in 75–90% of the cases The remaining part result as steroid resistant nephrotic syndrome, characterized...
Autores principales: | Angeletti, Andrea, Bruschi, Maurizio, Kajana, Xhuliana, La Porta, Edoardo, Spinelli, Sonia, Caridi, Gianluca, Lugani, Francesca, Verrina, Enrico Eugenio, Ghiggeri, Gian Marco |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10497215/ https://www.ncbi.nlm.nih.gov/pubmed/37705972 http://dx.doi.org/10.3389/fimmu.2023.1213203 |
Ejemplares similares
-
Circulating Anti-Rituximab Antibodies Do Not Affect Response to Rituximab in Steroid-Dependent Nephrotic Syndrome
por: Angeletti, Andrea, et al.
Publicado: (2022) -
Vaccines and nephrotic syndrome: efficacy and safety
por: Angeletti, Andrea, et al.
Publicado: (2022) -
Randomised controlled trial comparing rituximab to mycophenolate mofetil in children and young adults with steroid-dependent idiopathic nephrotic syndrome: study protocol
por: Lugani, Francesca, et al.
Publicado: (2021) -
Mechanisms Limiting Renal Tissue Protection and Repair in Glomerulonephritis
por: Angeletti, Andrea, et al.
Publicado: (2023) -
Microplastics and Kidneys: An Update on the Evidence for Deposition of Plastic Microparticles in Human Organs, Tissues and Fluids and Renal Toxicity Concern
por: La Porta, Edoardo, et al.
Publicado: (2023)